Results 151 to 160 of about 642,036 (246)

Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. [PDF]

Cochrane Database Syst Rev
Siristatidis CS, Yong LN, Maheshwari A, Ray Chaudhuri Bhatta S.   +3 more
europepmc   +1 more source

Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy. [PDF]

ESMO Open, 2023
Massarotti C, Stigliani S, Gazzo I, Lambertini M, Anserini P.   +4 more
europepmc   +1 more source

Association of GnRH Agonist Pretreatment with Reproductive Outcomes in Women ≥35 years with Diminished Ovarian Reserve Undergoing Frozen Embryo Transfer: A Large Retrospective Cohort Study

International Journal of Women's Health
Yueping Zhou, Zhiqi Liao, Yaxin Guo Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Yaxin Guo, Reproductive Medicine Center, Tongji ...
Zhou Y, Liao Z, Guo Y
doaj  

Outcomes of Patients With Familial Central Precocious Puberty due to Mutations of <i>MKRN3</i> Gene After Treatment With Gonadotropin-Releasing Hormone Agonist. [PDF]

Int J Endocrinol
Chen Z, Li W, Wang J, Dong Z, Li C, Wang W, Hu R, Ma X, Xiao Y, Lu W.   +9 more
europepmc   +1 more source

Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist Therapy: A Rare and Life-Threatening Complication. [PDF]

Cureus
Naghiyeva A, Smati N, Lucas CG, Page BR, Zilbermint M.   +4 more
europepmc   +1 more source

Modified cytoskeletal and extracellular matrix composition in the canine testis after long-acting gonadotropin-releasing hormone agonist deslorelin treatment. [PDF]

Andrology
Gram A, Abay M, Gram DY, Liman N, Müller L, Balogh O.   +5 more
europepmc   +1 more source

Gonadotropin-releasing hormone agonist (GnRH-a) pretreatment duration and letrozole supplementation for optimizing live birth rates in women with adenomyosis undergoing frozen-thawed embryo transfer (GOLD-FET): study protocol for a multicenter, 2 × 2 factorial randomized controlled trial in China. [PDF]

Trials
Xiong Y, Gu F, Du L, Gu J, Ke Z, Xu Y, Mol BW, Zheng B, Lin X, Xu Y.   +9 more
europepmc   +1 more source

Long-term outcomes of gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty. [PDF]

Ann Pediatr Endocrinol Metab
Hwangbo J, Kang E, Nam HK, Rhie YJ, Lee KH.   +4 more
europepmc   +1 more source

The Double-Edged Nature of the Gonadotropin-Releasing Hormone Agonist (GnRHa) Long Protocol: A Case of Paradoxical Ovarian Hyperstimulation During the Expected Downregulation Phase. [PDF]

J Clin Med
Nádasdi B, Kovács P, Csajbók ÉA, Wellinger K, Vágvölgyi A, Zádori J.   +5 more
europepmc   +1 more source

Optimal timing for triggering oocyte maturation during in vitro fertilization cycles varies between gonadotropin-releasing hormone agonist and human chorionic gonadotropin use. [PDF]

F S Rep
Enatsu N, Furuhashi K, Otsuki J, Enatsu K, Okamoto E, Kokeguchi S, Shiotani M.   +6 more
europepmc   +1 more source